EMA’s Clinical Data Policy One Year On: 50 Products, 3,000 Documents And ‘Positive Feedback’

Clinical study reports on 50 medicines, including orphans, biosimilars, generics and pediatric drugs, have been made publicly available since the European Medicines Agency’s policy on the proactive publication of clinical data was launched a year ago, the EMA has announced.

“This amounts to 3,279 clinical documents, totalling more than 1.3 million pages,” the agency said